Abstract
Sjögren-Larsson syndrome (SLS) is an inherited neurocutaneous disorder characterized by mental retardation, spasticity and ichthyosis. SLS patients have a profound deficiency in fatty aldehyde dehydrogenase (FALDH) activity. We have now cloned the human FALDH cDNA and show that it maps to the SLS locus on chromosome 17p11.2. Sequence analysis of FALDH amplified from fibroblast mRNA and genomic DMA from 3 unrelated SLS patients reveals distinct mutations, including deletions, an insertion and a point mutation. The cloning of FALDH and the identification of mutations in SLS patients opens up possibilities for developing therapeutic approaches to ameliorate the neurologic and cutaneous symptoms of the disease
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sjögren, T. & Larsson, T. Oligophrenia in combination with congenital ichthyosis and spastic disorders. Acta Psychiatr. Neurol. Scand. 32, 1–113 (1957).
Jagell, S., Gustavson, K.-H. & Holmgren, G. Sjögren-Larsson syndrome in Sweden: A clinical, genetic and epidemiological study. Clin. Genet. 19, 233–256 (1981).
Rizzo, W.B. Sjögren–Larsson syndrome. Semin. Dermatol. 12, 210–218 (1993).
Jagell, S. & Heijbel, J. Sjögren–Larsson syndrome: physical and neurological features. Helv. Paediatr. Acta. 37, 519–530 (1982).
Rizzo, W.B., Sjögren–Larsson syndrome. In Handbook of Clinical Neurology, (eds Vinken, RJ. & Bruyn, G.W.) (Elsevier, Amsterdam, in the press).
Rizzo, W.B. & Craft, D.A. Sjögren–Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts. J. Clin. Invest. 88, 1643–1648 (1991).
Rizzo, W.B., Dammann, A.L. & Craft, D.A. Sjögren–Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohohnicotinamide adenine dinucleotide oxidoreductase activity. J. Clin. Invest. 81, 738–744 (1988).
Rizzo, W.B. et al. Sjogren-Larsson syndrome: inherited defect in the fatty alcohol cycle. J. Pediatr. 115, 228–234 (1988).
Judge, M.R., Lake, B.D., Smith, V.V., Besley, G.T.N. & Harper, J.I. Depletion of alcohol (hexanol) dehydrogenase activity in the epidermis and jejunal mucosa in Sjogren-Larsson syndrome. J. Invest. Dermatol. 96, 632–634 (1990).
Kelson, T.L., Craft, D.A. & Rizzo, W.B. Carrier detection for Sjögren–Larsson syndrome. J. Inherit Metab. Dis. 15, 105–111 (1992).
Rizzo, W.B. et al. Prenatal diagnosis of Sjögren–Larsson syndrome using enzymatic methods. Prenat. Diagn. 14, 577–581 (1994).
Pigg, M. et al. The Sjögren–Larsson syndrome gene is close to D17S805 as determined by linkage analysis and allelic association. Nature Genet. 8, 361–364 (1994).
Rogers, G.R. et al. Genetic homogeneity in Sjögren–Larsson syndrome: linkage to chromosome 17p in families of different non-Swedish ethnic origins. Am. J. Hum. Genet. 57, 1123–1129 (1995).
Miyauchi, K. et al. Molecular cloning, sequencing, and expression of cDNA for rat liver microsomal aldehyde dehydrogenase. J. Biol. Chem. 266, 19536–19542 (1991).
Masaki, R., Yamamoto, A. & Toshiro, Y. Microsomal aldehyde dehydrogenase is localized to the endoplasmic reticulum via its carboxyl-terminal 35 amino acids. J. Cell Biol. 126, 1407–1420 (1994).
Hempel, J., Nicholas, H. & Lindahl, R. Aldehyde dehydrogenases: widespread structural and functional diversity within a shared framework. Prof. Sci. 2, 1890–1900 (1993).
Hiraoka, L.R., Hsu, L. & Hsieh, C.-L. Assignment of ALDH3 to human chromosome 17p11. 2 and ALDH5 to human chromsome 9p13. Genomics. 25, 323–325 (1995).
Yoshida, A., Hsu, L.C. & Yasunami, M. Genetics of human alcohol-metabolizing enzymes. Prog. Nucl. Acid Res. Molec. Biol. 40, 255–287 (1991).
Lindhal, R. Aldehyde dehydrogenases and their role in carcinogenesis. Grit Rev. Biochem. Mot. Biol. 27, 283–315 (1992).
Yoshida, A., Huang, I.-Y. & Ikawa, M. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc. Natl. Acad. Sci. USA 81, 258–261 (1984).
Richards, B. . et al. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum. Mol. Genet. 2, 159–163 (1993).
Sambrook, J., Fritsch, E.F. & Maniatis, T., T Molecular Cloning. A Laboratory Manual. 2nd ed (Cold Spring Harbor Press, 1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Laurenzi, V., Rogers, G., Hamrock, D. et al. Sjögren–Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat Genet 12, 52–57 (1996). https://doi.org/10.1038/ng0196-52
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0196-52
This article is cited by
-
Ichthyosis
Nature Reviews Disease Primers (2023)
-
Pharmacological treatments for cutaneous manifestations of inherited ichthyoses
Archives of Dermatological Research (2020)
-
Phenotypic and mutational spectrum of thirty-five patients with Sjögren–Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects
Journal of Human Genetics (2019)
-
Alkane biosynthesis by Aspergillus carbonarius ITEM 5010 through heterologous expression of Synechococcus elongatus acyl-ACP/CoA reductase and aldehyde deformylating oxygenase genes
AMB Express (2017)
-
Genome-wide analyses identify common variants associated with macular telangiectasia type 2
Nature Genetics (2017)